Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Updated results of a randomized, double-blind, placebo-controlled, multicenter phase III trial (RADIANT-3).
Manisha H. Shah
Disclosure not yet available
Tetsuhide Ito
Disclosure not yet available
Catherine Lombard-Bohas
Disclosure not yet available
Edward M. Wolin
Disclosure not yet available
Eric Van Cutsem
Disclosure not yet available
Carolin Sachs
Disclosure not yet available
Robert E. Winkler
Disclosure not yet available
Jeremie Lincy
Disclosure not yet available
Timothy J. Hobday
Disclosure not yet available
James C. Yao
Disclosure not yet available